
1. j virol methods. 2015 jun 15;218:40-5. doi: 10.1016/j.jviromet.2015.03.006. epub 
2015 mar 17.

a new quantitative pcr human parvovirus b19 genotypes.

toppinen m(1), norja p(2), aaltonen lm(3), wessberg s(4), hedman l(5),
söderlund-venermo m(2), hedman k(5).

author information: 
(1)university helsinki, department virology, haartmaninkatu 3, 00290
helsinki, finland. electronic address: mari.toppinen@helsinki.fi.
(2)university helsinki, department virology, haartmaninkatu 3, 00290
helsinki, finland.
(3)helsinki university hospital, department otorhinolaryngology-head neck 
surgery, haartmaninkatu 4, 00290 helsinki, finland.
(4)finnish red cross blood service, kivihaantie 7, 00310 helsinki, finland.
(5)university helsinki, department virology, haartmaninkatu 3, 00290
helsinki, finland; helsinki university hospital laboratory division,
haartmaninkatu 3, 00290 helsinki, finland.

parvovirus b19 (b19v) minute ssdna virus associated wide range of
diseases childhood erythema fetal death. primary infection, the
viral genomes persist lifelong solid tissues types. quantification 
the viral dna important timing primary infection, assessment of
tissue persistence screening blood donor plasma. study, present
a new pcr assay detection quantification well differentiation
of three b19v genotypes. new b19v qpcr designed target 154-bp
region ns1 area. serum, plasma solid tissue samples suitable 
testing assay. international reference panel parvovirus b19
genotypes utilized validate assay detection different genotypes
of b19v clinical material. panel member yielded, new qpcr, a
quantity similar one reported national institute biological
standards control (nibsc). qpcr specific b19v amplified and
quantified three genotypes detection sensitivities ≤10
copies/reaction. differentiation b19v genotypes performed sanger
sequencing amplified products.

copyright © 2015 elsevier b.v. rights reserved.

doi: 10.1016/j.jviromet.2015.03.006 
pmid: 25794796  [indexed medline]

